YP
GSK icon

YANKCOM Partnership’s GSK GSK Stock Holding History

YANKCOM Partnership’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Hold
324
– – 0.01% 235
2026
Q1 		$17.9K Sell
324
-267
-45% -$14.5K 0.01% 236
2025
Q4 		$29K Buy
+591
New +$27.6K 0.01% 218
2025
Q3 		– Sell
-86
Closed -$3.3K – 305
2025
Q2 		$3.3K Hold
86
– – ﹤0.01% 270
2025
Q1 		$3.33K Hold
86
– – ﹤0.01% 263
2024
Q4 		$2.91K Buy
+86
New +$3.1K ﹤0.01% 245

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

YANKCOM Partnership's GSK Position: Q2 2026 in Review

YANKCOM Partnership held its GSK (GSK) position steady in Q2 2026 at 324 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #235.

YANKCOM Partnership first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. The position peaked at $29K in Q4 2025. 602 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • YANKCOM Partnership held 324 shares of GSK worth $17K as of Q2 2026.
  • YANKCOM Partnership left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of YANKCOM Partnership's portfolio in Q2 2026, its #235 holding.
  • YANKCOM Partnership first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
  • YANKCOM Partnership's GSK position peaked at $29K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.